|
No Prescription
» Products » Alpha Index K

List of Drugs:
A
B
C
D
E
F
G
H
I
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Z
#
Products K:
Kamagra Oral Jelly Banana Flavor Viagra
Kamagra Oral Jelly Grape Flavor Viagra
KAMAGRA ORAL JELLY Mint Flav Viagra
KAMAGRA ORAL JELLY Orange Flav Viagra
Kamagra Oral Jelly Strawberry Flavor Viagra
Kamagra (Sildenafil)
Kamagra Tablets Viagra
KARVOL PLUS Generic Camphor
Keflex Generic Cephalexin
Keflex (Cephalexin)
Kenacort Oral Paste Kenalog in Orabase
Kenalogin Orbase Aristocort
Keppra Generic Levitiracetam
Ketanov Toradol
KETOROL Ketonic
Kinetal Trental
Klacid Biaxin
Klacid MR Biaxin
Klacid Suspension Biaxin
Klomen Clomid
Kolsin Generic Colchicine
Kytril Generic Granisetron
Previous
Next
No Prescription:
NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.


|